Can nocturnal hypertension predict cardiovascular risk? by Friedman, Oded & Logan, Alexander G
© 2009 Friedman and Logan, publisher and licensee Dove Medical Press Ltd. This is an Open Access article   
which permits unrestricted noncommercial use, provided the original work is properly cited.
Integrated Blood Pressure Control 2009:2 25–37
Integrated Blood Pressure Control
25
r e v I e w
Dovepress
open access to scientific and medical research
Open Access Full Text Article
submit your manuscript | www.dovepress.com
Dovepress 
Can nocturnal hypertension predict 
cardiovascular risk?
Oded Friedman1 
Alexander G Logan2
1Samuel Lunenfeld research Institute, 
Division of Nephrology, Mount 
Sinai Hospital, 2Mount Sinai Hospital 
and University Health Network 
and Department of Medicine, 
University of Toronto, Toronto, Canada
Correspondence:   Alexander G Logan  
Suite 435, Mount Sinai Hospital, 
600 University Avenue,   Toronto,  
Ontario, M5G1X5, Canada 
Tel +1 416-586-5187 
Fax +1 416-586-5039 
email alogan@mtsinai.on.ca
Abstract: Nocturnal hypertension and non-dipping of blood pressure during sleep are 
distinct entities that often occur together and are regarded as important harbingers of poor 
cardiovascular prognosis. This review addresses several aspects related to these blood pressure 
abnormalities including definitions, diagnostic limitations, pathogenesis and associated patient 
profiles, prognostic significance, and therapeutic strategies. Taken together, persistent nocturnal 
hypertension and non-dipping blood pressure pattern, perhaps secondary to abnormal renal 
sodium handling and/or altered nocturnal sympathovagal balance, are strongly associated with 
deaths, cardiovascular events, and progressive loss of renal function, independent of daytime 
and 24-hour blood pressure. Several pharmacological and non-pharmacological approaches 
may restore nocturnal blood pressure and circadian blood pressure rhythm to normal; however, 
whether this translates to a clinically meaningful reduction in unfavorable cardiovascular and 
renal consequences remains to be seen.
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Introduction
An appreciation of the normal sleep-wake cycle of blood pressure (BP) in humans, 
characterized by a nocturnal fall and diurnal rise, has been well established for 
several decades.1 Consequently, this has resulted in an increased awareness 
of nocturnal hypertension as well as various sleep BP pattern disturbances, 
gleaned non-invasively from the recordings provided by 24-hour ambulatory BP 
monitoring (ABPM).
Definitions
Nocturnal hypertension has been defined using various absolute nocturnal BP cut-offs. 
According to the American Heart Association Council on High Blood Pressure 
Research, nocturnal BP  115/65 is deemed optimal, 120/70 is deemed normal 
and 125/75 is deemed abnormal.2 Non-dipping is commonly defined as a 10% 
fall in nocturnal BP relative to diurnal BP (ie, [daytime BP – night-time BP]/daytime 
BP × 100%),2 arithmetically equivalent to a night-to-day BP ratio 0.9. Non-dippers 
have been further subdivided into either attenuated dippers (0% but 10% fall) or 
risers (0% fall). There is also a patient subset, situated at the opposite end of the 
dipping spectrum, referred to as extreme dippers (20% fall) that has been linked 
in some, although not all, studies with increased cardiovascular risk and mortality, 
perhaps related to nocturnal hypoperfusion and/or an exaggerated morning BP surge; 3–6 
however, this entity is not further discussed herein. Of note, although high nocturnal Integrated Blood Pressure Control 2009:2 26
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BP may be accompanied by a non-dipping pattern, both are 
not always concomitantly present and the pathophysiologic 
and clinical significance of each may differ.7
Diagnostic limitations
Over the years, a number of diagnostic limitations 
categorizing nocturnal BP and dipping status have been 
identified. First, there is no universal agreement on the 
definition of non-dipping. For example, in some reports, it is 
defined as higher sleep BP level than awake BP level, rather 
than the more commonly used definition of a 10% fall in 
night-time BP.8,9 Second, studies of repeated ABPM have 
questioned the reproducibility of dipping status and diagnos-
ing nocturnal hypertension using cut-off values, given the 
well-described phenomenon of regression to the mean. On 
repeated ABPM, expressing the decline in BP during sleep 
as a continuous variable (eg, percentage fall in nocturnal BP) 
was shown to be far more reproducible than its expression 
as a categorical variable (ie,using the traditionally adopted 
10% cut-off), given a loss of information.10 This is particu-
larly an issue for defining abnormalities of dipping status as 
definitions rest on a difference score of individual daytime 
and night-time BP levels.10–13 In a study of repeated ABPM, 
agreement in diagnosing nocturnal hypertension on the basis 
of two measurements was greater using an absolute noc-
turnal BP threshold value (Cohen’s kappa = 0.485 systolic 
BP) rather than the percentage nocturnal BP fall (Cohen’s 
kappa = 0.378 systolic BP).14 Because of better metrics, noc-
turnal hypertension using threshold values was also a better 
predictor of left ventricular hypertrophy than non-dipping 
BP pattern.15 Third, the dipping pattern of systolic BP has 
been shown to be more reproducible than that of diastolic 
BP in several,12,16,17 although not all,18,19 studies. Fourth, the 
methods used to define the night-time period have varied 
from arbitrarily fixed clock times to self-reported sleep times 
using diary entries or even, polysomnographically verified 
sleep times. With respect to the arbitrarily fixed clock time 
method, one improvement has involved the use of narrow 
clock intervals to exclude the transition period from 0600 to 
1000 h20 or 0700 to 1000 h21 in the morning and from 2000 
to 0000 h20 or 2300 to 0100 h in the evening.21 Recently, it 
was shown that different definitions significantly affect the 
classification of nocturnal BP dipping and its relation to 
left ventricular mass index and urinary albumin excretion 
as indices of hypertensive target organ damage.12,22 Fifth, 
failing to account for night-time awakenings23 and daytime 
naps24 has been associated with misclassification of nocturnal 
hypertension. Additionally, variations in nocturnal body 
position and diurnal physical activity affect night-time and 
daytime BP.25,26 On balance, BP dipping status appears to 
be more influenced by night-time factors than by daytime 
physical activity.27 Sixth, nocturnal BP may be unreliable 
as a prognostic marker for cardiovascular events and deaths 
among subjects with perceived sleep deprivation 2 hours 
during ABPM related to repeated cuff inflations.28 Finally, 
antihypertensive drug treatment and the timing of their 
administration can influence circadian BP profile.29,30
Pathophysiology
Although there have been several theories as to the 
pathogenesis of non-dipping including systemic and vascular 
inflammation and endothelial dysfunction,31 perhaps the 
two most cited explanations rest on abnormal renal sodium 
handling and disturbances in nocturnal autonomic or sympa-
thovagal balance. Further, the association of nocturnal hyper-
tension and non-dipping pattern with patient profiles provides 
further insights into mechanisms. Specifically, several patient 
characteristics have been associated with nocturnal hyperten-
sion and non-dipping BP pattern; not surprisingly, many of 
these states are associated with impaired renal capacity to 
excrete sodium and/or relative sympathoactivation.
Abnormal renal sodium handling
Many studies have shown an association between abnormal 
renal sodium handling and nocturnal hypertension and non-
dipping pattern of BP during sleep. In a recent study of a 
large group of African subjects, those with the lowest day-
to-night ratios of urinary sodium excretion had significantly 
higher night-time systolic BP and lower systolic BP dipping 
in both unadjusted and adjusted analyses.16 The ‘low daytime 
sodium excretors’ excreted three times less sodium during 
the day than during the night, whereas the ‘high daytime 
sodium excretors’ had a sodium excretion rate that was 46% 
higher during the day than during the night, although total 
daily sodium excretion was equivalent in both groups. These 
findings are in accord with earlier, smaller studies conducted 
in hospitalized subjects.32–34 In a study of Japanese patients 
with essential hypertension, non-dippers on a high sodium 
diet had a significantly higher night-time systolic BP and 
mean arterial pressure (MAP) and showed no nocturnal 
decrease in BP compared to the dippers.32 Furthermore, 
night-time urinary sodium excretion was significantly greater 
in non-dippers than dippers and there was a strong positive 
relationship between night-to-day ratios of urinary sodium 
excretion and MAP. When the non-dippers were placed on a 
sodium-restricted diet, there was a significant fall in systolic Integrated Blood Pressure Control 2009:2 27
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BP and MAP in the non-dippers and there was no longer a 
significant difference in the night-to-day ratios of urinary 
sodium excretion between non-dippers and dippers. Given 
a greater antinatriuresis during the day in the non-dippers, 
higher nocturnal BP, as a result of pressure-natriuresis with 
near infinite gain over a wide range of urinary sodium excre-
tion, may account for the greater proportion of urine sodium 
excreted at night to maintain total body sodium balance.35
Enhanced salt sensitivity of BP is often found in 
non-dippers35 and has been suggested as mediating nocturnal 
hypertension.33,34 Among black normotensive adolescents, 
a significantly greater proportion of non-dipping for MAP at 
50% was identified in those deemed salt sensitive (defined as 
a 5 mmHg BP difference between the high and low dietary 
salt states) as compared to 18.9% in those deemed salt resis-
tant.36 Further, a Japanese study revealed that the nocturnal 
fall of BP from daytime to night-time was only significant 
among salt resistant hypertensives (defined as a 10% BP 
difference between the high and low dietary salt states) 
compared to their salt sensitive hypertensive counterparts.32 
This has been attributed, in part, to a disturbed antinatriuretic 
response to postural change. Specifically, among hyperten-
sive subjects, although the urinary sodium excretion rate was 
found to be significantly less in the upright than the supine 
position in both non-dippers and dippers, the difference 
was magnified in the non-dippers (despite no difference in 
postural BPs) because of an exaggerated reduction in upright 
sodium excretion.37 Exaggerated antinatriuretic effects of 
postural change may also contribute to the high prevalence 
of supine nocturnal hypertension in patients with autonomic 
failure, possibly related to increased sensitivity to changes in 
plasma volume with re-entry into the circulation of peripheral 
interstitial fluid accumulated during the day.38,39
The renal sodium regulatory mechanisms that give rise to 
nocturnal hypertension and non-dipping BP pattern remain 
unclear. In the case of chronic kidney disease, reduced 
ultrafiltration capacity likely accounts for the blunting of the 
nocturnal fall in BP along with enhanced natriuresis at night.40 
However, many individuals with disturbed diurnal renal 
sodium excretion have normal glomerular function;16 in these 
instances, augmented tubular reabsorption of sodium during 
the day likely contributes to the genesis of the nocturnal BP 
and natriuretic abnormalities.35 In salt sensitive forms of 
hypertension such as primary aldosteronism, or patients with 
diabetes mellitus or metabolic syndrome, there is evidence 
of enhanced tubular sodium reabsorption that may account 
for non-dipping.34,40 Further evidence supporting a role for 
renal tubular sodium handling comes from studies of patients 
with essential hypertension showing a differential effect of 
hydrochlorothiazide, which inhibits sodium transport in 
the distal nephron, on nocturnal fall in BP in non-dippers 
compared to dippers;41,42 diuretic therapy restored the dipping 
BP pattern in non-dippers but had no effect in dippers.41
Nocturnal sympathovagal imbalance
Nocturnal sympathoexcitation has also been suggested 
as mediating nocturnal hypertension and non-dipping 
BP pattern.9,26 This is in contrast to the normal sleep-
wake cycle of sympathetic neural activity character-
ized by sympathoinhibition during sleep (particularly 
non-rapid-eye-movement sleep).43 In a cohort of normoten-
sive and hypertensive subjects, non-dippers were observed 
to have a reduced night-time fall in urine catecholamine 
levels and heightened alpha-1-adrenergic receptor respon-
siveness to phenylephrine (but similar beta-adrenergic 
receptor responsiveness to isoproterenol), unlike dippers.44 
A recent study found a significant inverse relationship 
between the degree of sympathetic activation, measured 
by muscle sympathetic nerve activity in the daytime, and 
the magnitude of night-time fall in BP.45 In that report, the 
increase in sympathetic activity was greatest in subjects 
demonstrating an increase in nocturnal BP (risers). The 
findings are in accord with results of earlier studies dem-
onstrating a higher mean daytime plasma norepinephrine 
level in risers9 and a greater reduction of night-time BP 
following administration of the alpha-adrenergic blocker, 
doxazosin.46 Several reports using power spectral analysis 
of heart rate variability suggest that a reduction in para-
sympathetic nervous system activity may also contribute 
to the non-dipping BP pattern in essential hypertension.47,48 
The causal mechanism(s) leading to sustained nocturnal 
sympathetic augmentation is still poorly understood, but 
may include the insulin resistance state, which frequently 
accompanies sympathetic activation45,49 and innate or 
acquired susceptibility to the pressor effects of salt.50,51 
However, changes in baroreflex sensitivity do not appear to 
account for abnormal dipping pattern as a study measuring 
it spontaneously or by the phenylephrine bolus technique 
found no significant difference between hypertensive 
dippers and non-dippers.52
Associations
A variety of factors including patient characteristics, clinical 
conditions, and dietary patterns have been reported to be 
associated with nocturnal hypertension and non-dipping. 
These links often provide some pathophysiologic insights.Integrated Blood Pressure Control 2009:2 28
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Patient characteristics
Multivariable assessment of a large cohort of untreated 
hypertensive men and women revealed a highly significant 
inverse linear correlation between the day-night systolic 
BP change and age in both sexes.53 The prevalence of the 
non-dipping BP pattern increased progressively with age, 
reaching 40% in subjects 70 years. Several studies have 
also noted increasing salt sensitivity of BP with increasing 
age, particularly among hypertensive patients, using pro-
vocative maneuvers to either contract or expand extracellular 
fluid volume.54,55 In fact, the presence of hypertension has 
been suggested as conferring a lower nocturnal fall in BP,56 
although this has not been unanimously confirmed.57 Blacks 
have been consistently shown to have a greater frequency 
of both reduced nocturnal fall in BP58–62 and salt sensitivity 
of BP63,64 than whites. Blacks also have higher ambulatory 
heart rates and lower heart rate variability than non-blacks, 
possibly reflecting greater impairment in sympathovagal bal-
ance in this racial group.65 There does not appear to be a sex 
difference in the prevalence of non-dipping;53 nonetheless, 
several studies have shown more adverse health effects in 
hypertensive women with blunted nocturnal fall in BP. In 
contrast to men, they have a greater left ventricular mass 
index66,67 and are more likely to develop a cardiovascular 
complication.68
Clinical conditions
Several studies have shown that non-dipping is more com-
monly found in clinical conditions, including hypertension, 
diabetes mellitus, impaired glucose tolerance, renal disease, 
autonomic failure, disrupted sleep, and sleep apnea. Over-
all, it is estimated that approximately 22% of patients with 
essential hypertension have a non-dipping pattern.26 Among 
treated hypertensive patients, non-dipping may also be partly 
related to the absence of uniform 24-hour therapeutic antihy-
pertensive coverage, perhaps especially in those treated with 
single morning doses and/or short-acting antihypertensive 
medications.29,69 We recently showed a significantly greater 
prevalence of non-dippers (particularly risers) in patients 
with refractory hypertension as compared to those with 
controlled hypertension and normal BP, matched for age, sex 
and BMI,70 with figures ranging from 66% to 79% reported 
by others.71,72 Previously, in a 3-month interventional trial of 
drug-resistant hypertension, patients randomized to receive 
antihypertensive treatment dictated by non-invasive hemody-
namic measurements were found to have significantly lower 
BP and better BP control than those receiving specialist care 
alone and the differences were attributed to a significantly 
higher final diuretic dosing.73 Such data suggest that covert 
extracellular fluid volume expansion may be a dominant 
feature accounting for apparent treatment resistance in 
refractory hypertension and may also explain our parallel 
observation of greater attenuation of the nocturnal dipping 
pattern in such patients.
There is a higher prevalence of non-dipping among 
patients with diabetes mellitus,53,74 particularly among those 
with higher night-time than day-time readings.8 This finding 
does not appear to be a consequence of increased nocturnal 
awakenings from nocturia due to osmotic diuresis and/or 
neurogenic bladder. Among subjects reporting having taken 
an uninterrupted afternoon siesta, diabetics displayed a 
similar naptime BP decline to their night-time BP decline, 
which was blunted as compared to the non-diabetic controls.75 
Several small studies have shown that insulin resistance in 
non-diabetic hypertensive subjects is also associated with a 
reduced nocturnal fall in BP.76–78 Mancia et al, however, did 
not find an increase in non-dipping pattern in patients with 
the metabolic syndrome, although less than one-third of these 
individuals had impaired glucose intolerance.79 Hermida et al 
recently reported a higher prevalence of non-dipping BP 
pattern in patients with the metabolic syndrome compared 
to those without this condition and they also had a higher 
BMI.80 Increased BMI, however, is not a characteristic feature 
of the non-dipping BP pattern as it was not significantly dif-
ferent among subjects dichotomized into 4 categories of the 
night-to-day ratio of systolic BP (extreme, normal, decreased, 
reverse) in a meta-analysis of several prospective population 
studies of 24-hour BP monitoring.81
Abnormal diurnal BP variability is present in patients 
with chronic kidney disease such that they are more likely 
non-dippers.82,83 For example, the mean nocturnal systolic 
BP change among patients with essential hypertension 
was found to be a decrease of 12.7 mmHg compared to an 
increase of 2.7 mmHg among hypertensive patients with 
renal parenchymal disease, despite matching for age, sex 
and 24-hour BP.84 Additionally, the decrease in unadjusted 
creatinine clearance following donor nephrectomy was found 
to correlate with the corresponding increase in the night-
to-day BP ratio but not the 24-hour, daytime or night-time 
BP.85 Non-dipping has also been linked to accelerated loss of 
renal function. In a retrospective cohort study of outpatients 
attending a hospital clinic, non-dipping was associated with 
subsequent deterioration in renal function that was indepen-
dent of baseline renal function, systolic BP load and other 
risk factors for renal impairment.86 Additionally, in a study 
of renal transplant recipients, non-dippers and risers had Integrated Blood Pressure Control 2009:2 29
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lower glomerular filtration rates, measured by iothalamate 
clearance, than dippers one year after transplantation; there 
was no difference in iothalamate glomerular filtration rates 
at the three week time point post-transplantation.87
Short habitual sleep duration may be associated with non-
dipping of nocturnal BP. In two separate studies, untreated 
hypertensive patients who were non-dippers were found to 
have significantly shorter durations of sleep by 0.3 hours in 
men and 0.5 hours in women (according to self-report)53 or 
by 81 minutes (according to wrist actigraphy),88 compared 
to their dipper counterparts; further multivariable analysis 
in one of these studies showed a positive linear correlation 
between the day-night systolic BP change and sleep 
duration.53 Moreover, poor sleep quality has also been 
suggested as being related to nocturnal hypertension. In a 
study of normotensive and hypertensive subjects with an 
apnea-hypopnea index (AHI) 10, the degree of nocturnal 
BP dipping was positively linked with the percentage of 
total sleep time occupied by stage 4 non-rapid eye move-
ment sleep (reflecting depth of sleep) and negatively linked 
with the percentage of wake time following sleep onset 
(reflecting sleep fragmentation).89 Similar findings of less 
time spent in stage 4 non-rapid eye movement sleep and 
sleep fragmentation with micro/arousals along with other 
qualitative disturbances have also been reported by others.90–92 
Notwithstanding the foregoing relations, sleep-disordered 
breathing, particularly obstructive sleep apnea-hypopnea 
(OSAH), has been strongly associated with non-dipping.93–96 
Notably, the vast majority of mechanistic studies linking 
OSAH and hypertension are disproportionately represented 
by those implicating sympathoactivation (whether gauged 
by plasma or urine catecholamines or microneurography), 
independent of obesity. For example, a recent study involved 
normotensive subjects who were classified as lean or obese 
with or without OSAH (according to BMI, waist-to-hip ratio 
and AHI) and matched for age and sex. Relative to the non-
OSAH lean group, muscle sympathetic nerve activity was 
significantly and similarly greater in both the OSAH lean 
group and in the non-OSAH obese group; the increase was 
even more pronounced in the OSAH obese group.97
Dietary patterns
Several studies have recognized an increased prevalence 
of non-dipping status in obese patients, particularly in 
women.44,67,98 Salt sensitivity may underlie raised night-time 
BP in obese individuals. For example, in a study of obese and 
non-obese adolescents, when the obese group was changed 
from a high salt to a low salt diet there was a greater fall in their 
BP compared to non-obese group.99 This increased sensitivity 
to dietary salt intake may be a manifestation of the hyperad-
renergic state that is a feature of abdominal obesity and often 
ascribed to the central sympathetic effects of hyperinsulinemia 
and hyperleptinemia.100 The prevalence of OSAH, associated 
with increased likelihood of non-dipping pattern,93–96 also pro-
gressively increases as BMI and associated markers of obesity 
(eg, neck circumference, waist-to-hip ratio) increase.101
Dietary monovalent cation intake patterns, characterized 
by a high sodium or low potassium content, are also recog-
nized as favoring a non-dipping BP pattern, particularly in 
salt sensitive individuals.102 The hypertensinogenic effects of 
a low potassium diet have been attributed, at least partly, to 
renal sodium retention.103 In the Dietary Approaches to Stop 
Hypertension (DASH) Trial, the BP of individuals randomly 
assigned to the ‘combination’ (DASH) diet that emphasized 
low fat dairy products, fruits and vegetables, thus containing 
high amounts of calcium and potassium,104 was significantly 
lower during the day and at night compared to the BP of 
those consuming the ‘typical American’ diet; however, the 
high quality (DASH) diet did not significantly affect dipping 
status.105 This is a surprising finding in view of the evidence 
from the same group of investigators that the DASH diet 
increased, thus improving, the pressure-natriuresis slope 
(ie, reduced salt-sensitivity).106 Possibly misclassification 
error from the use of a fixed clock method to determine dip-
ping status might explain the negative result.
Epidemiological studies
Numerous observational studies have emerged addressing 
the prognostic significance of nocturnal hypertension and 
non-dipping BP pattern on mortality and cardiovascular 
disease.
Considerations
The presence of nocturnal hypertension in one indi-
vidual but not the other would be expected to connote 
a greater 24-hour BP load if daytime BP levels were 
otherwise equivalent in the two individuals. Certainly, 
then, one would not be surprised to find a larger burden of 
hypertensive target organ damage in the former individual. 
What remains less clear is whether night-time BP is able 
to predict such vascular insult independent of daytime or 
24-hour BP and perhaps further, whether its predictive 
ability is superior to that provided by daytime BP. If such 
an association is truly not spurious, several explanations 
could be held accountable. First, a proper interpretation of 
any observational study must be tempered by the potential Integrated Blood Pressure Control 2009:2 30
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for residual confounding. For example, if nocturnal 
hypertension were simply a marker for underlying illnesses 
linked to deaths and cardiovascular events,81,107 then any 
association identified with nocturnal hypertension may be 
inaccurately estimated if the given state and/or condition 
were either undefined or poorly defined. In addition, 
it may not be nocturnal hypertension per se but rather its 
underlying pathophysiologic state (eg, heightened sympa-
thetic neural tone) that bestows vascular injury. Second, 
a cause-effect relation may indeed apply. The sleep state 
is typically associated with the minimum BP necessary to 
maintain organ perfusion; perhaps then, if also given a per-
missive hormonal milieu, susceptibility to vascular target 
organ damage may demonstrate circadian variability for 
a given BP load marked by an increase during sleep.108,109 
Moreover, for the cerebrum, its vasculature may be less 
protected from hydrostatic (gravitational) forces when 
recumbent during sleep than when erect or sitting.110 Third, 
an effect-cause relation can be argued instead, particularly 
with cross-sectional and case-control studies. Specifically, 
nocturnal hypertension may simply reflect more extensive 
target organ damage placing the patient in a high-risk 
group, as opposed to having a direct effect. Fourth, in view 
of a narrower dispersion of nocturnal BP values compared 
to diurnal BP values, partly related to ambulatory physical 
activity,111 night-time BP would be expected to perform 
mathematically, but not necessarily biologically, better as 
a predictor than daytime BP.7
Summary of findings
On the basis of ABPM performed 1 to 5 years earlier, a 
case-control study of hypertensive subjects revealed a 
significantly lower nocturnal fall in BP among cases as 
compared to controls (based on the occurrence of a fatal or 
non-fatal cardiovascular event) but only in women, despite 
matching for several covariates including daytime BP.68 
However, the vast majority of more recent studies focusing 
on the prognostic implications of nocturnal hypertension 
have been prospective cohort in design. Of course, there is 
also a robust body of literature that speaks to the association 
between nocturnal hypertension and a multitude of unfavor-
able structural (eg, cardiac chamber dilatation, ventricular 
hypertrophy, carotid intima-media thickening, silent lacunae, 
leukoaraiosis, brain microbleeds) and functional (eg, diastolic 
dysfunction) cardiovascular consequences.112–120 Tables 1 
to 3 summarize the varied patient populations enrolled in 
and the methodological aspects and accompanying results of 
larger studies (sample size 500) that examined the clinical 
endpoints of all-cause mortality, cardiovascular mortality 
and/or cardiovascular morbidity. As evident, additional 
adjustments for either daytime or 24-hour BP were not 
uniformly made in such studies to allow for a determination 
Table 1 Studies addressing independent prognostic significance of nocturnal blood pressure on all-cause mortality and/or cardiovascular 
mortality/morbidity
Primary author Year Source of publication Country of primary 
author’s affiliation
Sample size Study design
Ohkubo5,145 1997a
2002
Am J Hypertens  
J Hypertens
Japan 1542 Prospective cohort
Staessen6 1999 JAMA Belgium 808 Prospective cohort
Dolan122 2005 Hypertension Ireland 5292 Prospective cohort
Ben-Dov121 2007 Hypertension Israel 3957 Prospective cohort
Fagard123 2008 Hypertension Belgium 3468 Meta-analysis
Bjorklund146 2004 J Hypertens Sweden 872 Prospective cohort
Kikuya124 2005 Hypertension Japan 1332 Prospective cohort
Ingelsson147 2006 JAMA Sweden 951 Prospective cohort
Sega148 2005 Circulation Italy 2051 Prospective cohort
Boggia81 2007 Lancet Uruguay 7458 Meta-analysis
Clement149 2003 N Engl J Med Belgium 1963 Prospective cohort
Hansen150,151 2005
2006
Hypertension  
Am J Hypertens
Denmark 1700 Prospective cohort
verdecchia152 1994 Hypertension Italy 959 Prospective cohort
Brotman153 2008 Am J Hypertens USA 621 retrospective cohort
aPilot analysis.Integrated Blood Pressure Control 2009:2 31
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of the independent prognostic significance of night-time BP. 
Regardless, the bulk of the existing data suggests that noc-
turnal hypertension, whether expressed as a categorical or 
continuous predictor, is strongly associated with deaths and/or 
cardiovascular events. For example, in the Japanese general 
population, a 5% attenuation in the nocturnal BP fall was 
associated with a 20% increase in cardiovascular mortality, 
even among individuals with a normal 24-hour BP (defined 
as 135/80).5 In fact, several studies have also found that 
night-time BP, independent of daytime BP, may predict death 
and/or adverse cardiovascular outcomes better than daytime 
BP.6,81,121–124 For instance, among untreated hypertensive 
patients, an increase of 10 mmHg in daytime or night-time 
BP was associated with hazard ratios (HRs) for cardiovascular 
mortality of 1.12 (daytime systolic) compared to 1.21 (night-
time systolic) and 1.04 (daytime diastolic; not significant) 
compared to 1.19 (night-time diastolic), after adjustment for 
the other BP.122 In a substudy of the Systolic Hypertension in 
Europe (Syst-Eur) trial, a 10-mmHg increase in night-time 
systolic BP was more predictive for all-cause deaths (adjusted 
HR 1.21), cardiovascular deaths (adjusted HR 1.21) and fatal 
and non-fatal cardiovascular events (adjusted HR: 1.26) than 
a comparable increase in daytime systolic BP (adjusted HRs 
0.93, 1.03 and 0.94, respectively; not significant).6
The non-dipping BP pattern also predicted total mortality 
and cardiovascular events compared to the normal or extreme 
dipping pattern, independent of cohort and confounding 
variables and after adjustment for 24-hour BP, in a large 
meta-analysis of prospective studies from Europe, Asia and 
South America.81 Similarly the night-to-day BP ratio treated as 
a continuous variable predicted all-cause mortality, again inde-
pendent of 24-hour BP and confounding variables, in a smaller 
meta-analysis of only European prospective studies.123 Reverse 
dipping was the strongest predictor of total mortality and car-
diovascular events in fully adjusted models.81 In this study, they 
were older, more frequently on antihypertensive medications and 
more likely to have a history of diabetes mellitus or previous 
cardiovascular disease, indicating that these individuals were at 
high risk. Compared to night-time BP, however, non-dipping BP 
pattern and night-to-day BP ratio were less consistent predic-
tors of cardiovascular mortality and non-fatal events in fully 
adjusted analyses,81,123 thus making them less important targets 
for interventions than absolute nocturnal BP level.
Therapeutic strategies
Whether greater effort should be expended on achieving 
night-time BP control and reversal of the non-dipping pattern 
over and above the attainment of daytime and 24-hour 
BP control so as to reap a greater reduction in deaths and 
cardiovascular events remains uncertain. Nonetheless, several 
strategies have been suggested as preferentially reducing night-
time BP with restoration of the normal circadian BP rhythm.
Both therapeutic lifestyle changes and pharmacological 
approaches are associated with conversion from non-dipper 
to dipper status. Two Japanese studies revealed that 
therapeutic interventions, namely dietary salt restriction and 
Table 2 Studies addressing independent prognostic significance of nocturnal blood pressure on all-cause mortality and/or cardiovascular 
mortality/morbidity
Primary 
author
Age (yrs) Male (%) BMI (kg/m2) Current/exsmoker (%) DM (%) Prevalent 
CVD (%)
Mean daytime 
BP (mmHg)
HTN (%)
Ohkubo5,145 61.6 36.6 NA 21.7 NA 4.5 128.6/76.1 30.7
Staessen6 69.6 38.5 26.7 35.5 NA 26.6 151.4/84.1 100
Dolan122 53.3 46.3 27.4 23.8 5.2 10.6 146.1/89.0 100
Ben-Dov121 55.0 47.0 27.2 NA 9.0 NA NA 70.4
Fagard123 60.8 44.8 27.7 13.7 8.4 0 143.5/87.1 100
Bjorklund146 71.0 100 26.0 20.6 13.5 0 NA 30.1
Kikuya124 61.8 34.5 NA 20.4 17.4 5.6 128.9/76.1 30.4
Ingelsson147 50.0 100 26.2 20.4 10.0 13.9 140.0/79.0 49.2
Sega148 52.9 52.8 NA 28.4 2.3 4.8 129.0/81.4 44.2
Boggia81 56.8 54.3 NA 29.3 7.5 8.3 132.4/80.1 46.1
Clement149 56.4 51.3 27.9 17.2 11.0 5.9 139.1/88.3 100
Hansen150,151 55.8 47.9 25.3 44.3 2.2 0 131.0/78.0 8.9
verdecchia152 52.9 49.8 27.0 23.7 9.8 3.1 146.4/93.0 100
Brotman153 61.3 48.1 27.8 21.1 10.8 13.5 NA 74.4
Abbreviations: BMI, body mass index; BP, blood pressure; CvD, cardiovascular disease; DM, diabetes mellitus; HTN, hypertension; NA, not available.Integrated Blood Pressure Control 2009:2 32
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diuretic therapy, which reduce total body sodium content were 
able to restore the normal dipping pattern of BP in salt sensi-
tive hypertensive patients (defined as a 10% BP difference 
between the high and low dietary salt states) unlike their salt 
resistant hypertensive counterparts.32,41 Similarly, intensified 
ultrafiltration in hemodialysis patients initially identified 
as risers led to a conversion to either dipper or attenuated 
dipper status, in the majority of cases.125 In addition to dietary 
sodium, among 58 black normotensive adolescents, a 3-week 
high potassium diet was able to revert salt sensitive (defined as 
a 5 mmHg BP difference between the high and low dietary 
salt states) individuals originally deemed non-dippers to 
Table 3 Studies addressing independent prognostic significance of nocturnal blood pressure on all-cause mortality and/or cardiovascular 
mortality/morbidity
Primary 
author
F/U (yrs) Ascertainment of 
nighttime period
Adjusted HR for  
all-cause mortality
Adjusted HR for  
cardiovascular mortality
Adjusted HR for  
cardiovascular morbiditya
Ohkubo5,145 5.1  
9.2
Sleep diary riser: 2.12  
Attenuated dipper: 1.35 (NS)
riser: 4.97b and 3.79c  
Attenuated dipper: 2.88b and 2.66c  
Non-dipper and 24-hour  
BP  135/80: 5.37  
Non-dipper and 24-hour  
BP  135/80: 2.35
NA
Staessen6 4.4 0000–0600 h 10 mmHg ↑ sBP: 1.21b 10 mmHg ↑ sBP:  
1.21b (NS)
10 mmHg ↑ sBP: 1.26b  
10% ↑ night-to-day  
sBP ratio: 1.41c
Dolan122 7.9 0100–0600 h 10 mmHg ↑ sBP: 1.18b  
10 mmHg ↑ dBP: 1.23b
10 mmHg ↑ sBP: 1.21b  
10 mmHg ↑ dBP: 1.19b
NA
Ben-Dov121 6.5 Sleep diary riser: 1.96*  
Attenuated dipper: 1.30b
NA NA
Fagard123 6.7 0000–0600 h 1 SD ↑ sBP: 1.34b  
1 SD ↑ dBP: 1.28b
1 SD ↑ sBP: 1.34b  
1 SD ↑ dBP: 1.40b
1 SD ↑ sBP: 1.36b  
1 SD ↑ dBP: 1.21b
Bjorklund146 6.6 0000–0600 h NA NA 1 SD ↑ sBP: 1.18  
1 SD ↑ dBP: 1.05 (NS)
Kikuya124 10.8 Sleep diary NA 10 mmHg ↑ sBP: 1.32* NA
Ingelsson147 9.1 0000–0600 h NA NA 1 SD ↑ sBP: 1.41c (NS)  
1 SD ↑ dBP: 1.47c  
(heart failure hospitalization)
Sega148 10.9 2300–0700 h 10 mmHg ↑ sBP: 1.42  
10 mmHg ↑ dBP: 1.47
10 mmHg ↑ sBP: 1.75  
10 mmHg ↑ dBP: 1.87
NA
Boggia81 9.6 0000–0600 h 
(europe, South 
America)  
2200–0400 h (Asia)
1 SD ↑ sBP: 1.22b  
1 SD ↑ dBP: 1.20*  
riser: 1.56c  
Attenuated dipper: 1.19c
1 SD ↑ sBP: 1.22b  
1 SD ↑ dBP: 1.24b  
riser: 1.45c  
Attenuated dipper: 1.08c (NS)
1 SD ↑ sBP: 1.21b  
1 SD ↑ dBP: 1.20b  
riser: 1.30c  
Attenuated dipper: 1.05c (NS)
Clement149 5.0 0000–0600 h 1 SD ↑ sBP: 1.06 (NS)  
1 SD ↑ dBP: 1.07 (NS)
NA 1 SD ↑ sBP: 1.27  
1 SD ↑ dBP: 1.18 (NS)
Hansen150,151 9.5 Diary 10 mmHg ↑ sBP: 1.19  
10 mmHg ↑ dBP: 1.35
10 mmHg ↑ sBP: 1.41  
10 mmHg ↑ dBP: 1.85
10 mmHg ↑ sBP: 1.27  
10 mmHg ↑ dBP: 1.54  
Non-dipper and daytime  
BP  135/85: 1.68c  
Non-dipper and daytime  
BP  135/85: 0.58c (NS)
verdecchia152 3.2 1000–0600 h NA NA Non-dipper and male: 1.04 (NS) 
Non-dipper and female: 6.26
Brotman153 6.3 2300–0600 h Non-dipper: 1.47c NA NA
aIncludes fatal and non-fatal cardiovascular events unless otherwise specified.
bIncludes adjustment for daytime blood pressure.
cIncludes adjustment for 24-hour blood pressure.
Abbreviations: BP, blood pressure; dBP, diastolic blood pressure; F/U, follow-up; HR, hazard ratio; NA, not available; NS, not significant; sBP, systolic blood pressure; SD, standard 
deviation.Integrated Blood Pressure Control 2009:2 33
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dippers, which was unlike both their salt resistant counterparts 
as well as the usual diet control group in which nearly all 
such individuals remained non-dippers.126 Correspondingly, 
among normotensive men, potassium supplementation was 
found to dose-dependently suppress salt sensitivity (defined 
as an increase in mean BP  3 mmHg with salt loading), par-
ticularly in blacks who had a greater frequency and severity 
of salt sensitivity.63 A significant reduction of night-time BP 
following a 1-year multidisciplinary weight loss program 
was observed among normotensive obese women.127 More-
over, in morbidly obese (body mass index BMI  35 kg/m2) 
hypertensive patients, bariatric surgery restored the normal 
circadian rhythm in non-dippers from a nocturnal systolic BP 
fall of 4% to 16.4%.128 In parallel, following the institution of 
a 20-week weight loss program, a decreased salt sensitivity 
of BP was observed but only in those who had successfully 
lost more than 1 kg of body weight.99
In the area of nocturnal sympathoexcitation, a signifi-
cant reduction of nocturnal BP following night-time dosing 
of an alpha-1-adrenergic blocker in hypertensive patients 
was identified but in non-dippers only.129 This differential 
effect, however, has been observed with other classes of 
antihypertensive agents, arguing against the specificity of 
the response.42,130 Pharmacokinetic and pharmacodynamic 
differences between various antihypertensive medications 
and their times of administration (‘chronotherapy’) may be 
important factors in determining nocturnal antihypertensive 
effects. For example, despite equivalent daytime BP control, 
differential antihypertensive effects on night-time BP were 
demonstrated between a long-acting calcium channel blocker 
and a similarly long-acting angiotensin converting enzyme 
inhibitor in a group of elderly hypertensive patients.131 
Nocturnal dosing of antihypertensive agents has also been 
associated with conversion from attenuated dipper or riser to 
dipper status in both controlled and refractory hypertensive 
patient populations.130,132–135 Uncontrolled short-term 
studies have revealed reductions in night-time BP readings 
along with transition from non-dipper to dipper status 
among normotensive and hypertensive subjects following 
nocturnal application of therapeutic continuous positive 
airway pressure (CPAP),136–138 which has been associated 
with sympathoinhibition unlike nocturnal application of 
subtherapeutic CPAP or oxygen.139 In patients with end-stage 
renal disease, renal transplantation has been associated with 
a significant lowering of the prevalence of non-dipping 
from 73% within the first year after transplantation to 27% 
following the first year after transplantation, independent of 
24-hour BP and concomitant medication changes,140 with the 
nocturnal BP fall correlating with renal allograft function.87 
Finally, in randomized parallel and crossover trials, nocturnal 
administration of exogenous melatonin was associated with 
a significant reduction of night-time BP, especially among 
non-dippers, unlike daytime BP and in some cases, this could 
not be entirely explained on the basis of an improvement in 
sleep.141–143 Non-dipping in subjects with type 2 diabetes 
mellitus has been found to relate more closely to post-prandial 
glycemic excursions, rather than fasting hyperglycemia.144 
However, whether improvements in glycemic control as well 
as sleep quality and duration translate into normalization of 
the circadian BP rhythm remains to be seen.
Conclusions
Awareness of the normal sleep–wake cycle of BP has resulted 
in an increasing appreciation for the significance of non-
dipping, a concept often used to construe nocturnal hyperten-
sion. Notwithstanding various limitations, principally related 
to its reproducibility, the identification of nocturnal hyperten-
sion has been shown to predict deaths and/or adverse car-
diovascular events both independent of and often superior to 
daytime BP. Several patient profiles have been associated with 
its occurrence (eg, older age, black race, diabetes mellitus, 
obesity, chronic kidney disease, sleep-related disturbances); 
moreover, many of these states are associated with 
sympathoexcitation and/or augmented salt sensitivity sug-
gesting a common pathophysiologic basis. Further, a number 
of therapeutic strategies (eg, dietary salt restriction, diuretic 
therapy, dietary potassium liberalization, weight loss, chro-
notherapy, nocturnal CPAP) have demonstrated restorative 
capacity for the normal circadian BP rhythm. Nevertheless, 
whether greater effort expended on achievement of night-time 
BP control above and beyond daytime BP results in a greater 
improvement in patient outcomes remains to be seen.
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